Geneva, March 23 -- International Clinical Trials Registry received information related to the study (ChiCTR2600120247) titled 'Study on the Efficacy and Safety of Intratonsillar Immunotherapy for Allergic Rhinitis' on March 11.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: The Fifth Affiliated Hospital of Sun Yat-sen University
Condition:
allergic rhinitis
Intervention:
Control Group (SCIT):Subcutaneous Immunotherapy (SCIT)
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-03-20
Target Sample Size: Control Group (SCIT):30;Experimental Group (ITIT):30;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=312587
Published by...